Cargando…
Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
BACKGROUND: Patients with Chagas disease have migrated to cities, where obesity, hypertension and other cardiac risk factors are common. METHODOLOGY/PRINCIPAL FINDINGS: The study included adult patients evaluated by the cardiology service in a public hospital in Santa Cruz, Bolivia. Data included ri...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872643/ https://www.ncbi.nlm.nih.gov/pubmed/20502520 http://dx.doi.org/10.1371/journal.pntd.0000688 |
_version_ | 1782181243159314432 |
---|---|
author | Hidron, Alicia I. Gilman, Robert H. Justiniano, Juan Blackstock, Anna J. LaFuente, Carlos Selum, Walter Calderon, Martiza Verastegui, Manuela Ferrufino, Lisbeth Valencia, Eduardo Tornheim, Jeffrey A. O'Neal, Seth Comer, Robert Galdos-Cardenas, Gerson Bern, Caryn |
author_facet | Hidron, Alicia I. Gilman, Robert H. Justiniano, Juan Blackstock, Anna J. LaFuente, Carlos Selum, Walter Calderon, Martiza Verastegui, Manuela Ferrufino, Lisbeth Valencia, Eduardo Tornheim, Jeffrey A. O'Neal, Seth Comer, Robert Galdos-Cardenas, Gerson Bern, Caryn |
author_sort | Hidron, Alicia I. |
collection | PubMed |
description | BACKGROUND: Patients with Chagas disease have migrated to cities, where obesity, hypertension and other cardiac risk factors are common. METHODOLOGY/PRINCIPAL FINDINGS: The study included adult patients evaluated by the cardiology service in a public hospital in Santa Cruz, Bolivia. Data included risk factors for T. cruzi infection, medical history, physical examination, electrocardiogram, echocardiogram, and contact 9 months after initial data collection to ascertain mortality. Serology and PCR for Trypanosoma cruzi were performed. Of 394 participants, 251 (64%) had confirmed T. cruzi infection by serology. Among seropositive participants, 109 (43%) had positive results by conventional PCR; of these, 89 (82%) also had positive results by real time PCR. There was a high prevalence of hypertension (64%) and overweight (body mass index [BMI] >25; 67%), with no difference by T. cruzi infection status. Nearly 60% of symptomatic congestive heart failure was attributed to Chagas cardiomyopathy; mortality was also higher for seropositive than seronegative patients (p = 0.05). In multivariable models, longer residence in an endemic province, residence in a rural area and poor housing conditions were associated with T. cruzi infection. Male sex, increasing age and poor housing were independent predictors of Chagas cardiomyopathy severity. Males and participants with BMI ≤25 had significantly higher likelihood of positive PCR results compared to females or overweight participants. CONCLUSIONS: Chagas cardiomyopathy remains an important cause of congestive heart failure in this hospital population, and should be evaluated in the context of the epidemiological transition that has increased risk of obesity, hypertension and chronic cardiovascular disease. |
format | Text |
id | pubmed-2872643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28726432010-05-25 Chagas Cardiomyopathy in the Context of the Chronic Disease Transition Hidron, Alicia I. Gilman, Robert H. Justiniano, Juan Blackstock, Anna J. LaFuente, Carlos Selum, Walter Calderon, Martiza Verastegui, Manuela Ferrufino, Lisbeth Valencia, Eduardo Tornheim, Jeffrey A. O'Neal, Seth Comer, Robert Galdos-Cardenas, Gerson Bern, Caryn PLoS Negl Trop Dis Research Article BACKGROUND: Patients with Chagas disease have migrated to cities, where obesity, hypertension and other cardiac risk factors are common. METHODOLOGY/PRINCIPAL FINDINGS: The study included adult patients evaluated by the cardiology service in a public hospital in Santa Cruz, Bolivia. Data included risk factors for T. cruzi infection, medical history, physical examination, electrocardiogram, echocardiogram, and contact 9 months after initial data collection to ascertain mortality. Serology and PCR for Trypanosoma cruzi were performed. Of 394 participants, 251 (64%) had confirmed T. cruzi infection by serology. Among seropositive participants, 109 (43%) had positive results by conventional PCR; of these, 89 (82%) also had positive results by real time PCR. There was a high prevalence of hypertension (64%) and overweight (body mass index [BMI] >25; 67%), with no difference by T. cruzi infection status. Nearly 60% of symptomatic congestive heart failure was attributed to Chagas cardiomyopathy; mortality was also higher for seropositive than seronegative patients (p = 0.05). In multivariable models, longer residence in an endemic province, residence in a rural area and poor housing conditions were associated with T. cruzi infection. Male sex, increasing age and poor housing were independent predictors of Chagas cardiomyopathy severity. Males and participants with BMI ≤25 had significantly higher likelihood of positive PCR results compared to females or overweight participants. CONCLUSIONS: Chagas cardiomyopathy remains an important cause of congestive heart failure in this hospital population, and should be evaluated in the context of the epidemiological transition that has increased risk of obesity, hypertension and chronic cardiovascular disease. Public Library of Science 2010-05-18 /pmc/articles/PMC2872643/ /pubmed/20502520 http://dx.doi.org/10.1371/journal.pntd.0000688 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Hidron, Alicia I. Gilman, Robert H. Justiniano, Juan Blackstock, Anna J. LaFuente, Carlos Selum, Walter Calderon, Martiza Verastegui, Manuela Ferrufino, Lisbeth Valencia, Eduardo Tornheim, Jeffrey A. O'Neal, Seth Comer, Robert Galdos-Cardenas, Gerson Bern, Caryn Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title | Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title_full | Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title_fullStr | Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title_full_unstemmed | Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title_short | Chagas Cardiomyopathy in the Context of the Chronic Disease Transition |
title_sort | chagas cardiomyopathy in the context of the chronic disease transition |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872643/ https://www.ncbi.nlm.nih.gov/pubmed/20502520 http://dx.doi.org/10.1371/journal.pntd.0000688 |
work_keys_str_mv | AT hidronaliciai chagascardiomyopathyinthecontextofthechronicdiseasetransition AT gilmanroberth chagascardiomyopathyinthecontextofthechronicdiseasetransition AT justinianojuan chagascardiomyopathyinthecontextofthechronicdiseasetransition AT blackstockannaj chagascardiomyopathyinthecontextofthechronicdiseasetransition AT lafuentecarlos chagascardiomyopathyinthecontextofthechronicdiseasetransition AT selumwalter chagascardiomyopathyinthecontextofthechronicdiseasetransition AT calderonmartiza chagascardiomyopathyinthecontextofthechronicdiseasetransition AT verasteguimanuela chagascardiomyopathyinthecontextofthechronicdiseasetransition AT ferrufinolisbeth chagascardiomyopathyinthecontextofthechronicdiseasetransition AT valenciaeduardo chagascardiomyopathyinthecontextofthechronicdiseasetransition AT tornheimjeffreya chagascardiomyopathyinthecontextofthechronicdiseasetransition AT onealseth chagascardiomyopathyinthecontextofthechronicdiseasetransition AT comerrobert chagascardiomyopathyinthecontextofthechronicdiseasetransition AT galdoscardenasgerson chagascardiomyopathyinthecontextofthechronicdiseasetransition AT berncaryn chagascardiomyopathyinthecontextofthechronicdiseasetransition AT chagascardiomyopathyinthecontextofthechronicdiseasetransition |